Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arca Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ABIO
Nasdaq
8731
http://arcabio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arca Biopharma Inc
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
- May 5th, 2022 8:15 pm
ARCA biopharma Announces First Quarter 2022 Financial Results
- May 2nd, 2022 8:15 pm
ARCA biopharma Establishes Special Committee of the Board of Directors
- Apr 18th, 2022 8:30 pm
Albioma : Governance changes
- Apr 5th, 2022 5:35 am
ARCA biopharma's Tissue Factor Inhibitor Disappoints In Mid-Stage COVID-19 Study
- Apr 1st, 2022 11:09 am
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
- Mar 31st, 2022 8:15 pm
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
- Mar 14th, 2022 8:15 pm
Battalion Oil Corporation Announces Fourth Quarter and Full Year 2021 Financial and Operating Results
- Mar 7th, 2022 9:30 pm
We're Keeping An Eye On ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
- Feb 8th, 2022 9:21 am
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2
- Jan 4th, 2022 1:30 pm
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
- Dec 2nd, 2021 1:30 pm
ClearPoint Neuro (NASDAQ:CLPT) shareholders are still up 635% over 3 years despite pulling back 13% in the past week
- Nov 20th, 2021 12:01 pm
ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th
- Nov 9th, 2021 9:15 pm
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
- Nov 2nd, 2021 8:15 pm
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
- Oct 29th, 2021 11:03 am
ARCA Biopharma Stock Gains As Safety Committee Recommends COVID-19 Trial To Continue Unchanged
- Oct 29th, 2021 10:26 am
ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy and Safety Data
- Oct 28th, 2021 8:30 pm
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
- Sep 16th, 2021 12:30 pm
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
- Aug 16th, 2021 12:05 pm
We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth
- Aug 12th, 2021 5:15 am
Scroll